You are viewing: China Urology Devices Market analysis
Part of: Urology Devices Market (Global)

The China Urology Devices Market was valued at $2663.3 Million in 2025 and projected to reach to $3880.8 Million by 2030, representing a compound annual growth rate of 7.8%. China's urology devices market is positioned for sustained growth through 2030, driven by demographic shifts, healthcare modernization, and rising disease prevalence.

China Urology Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Urology Devices Market Trends and Insights

  • This growth trajectory reflects China's aging population, rising prevalence of urological conditions, and increasing healthcare expenditure across the nation.
  • China's market is outpacing the global average of 6% CAGR, driven by enhanced diagnostic capabilities and improved access to advanced treatment options in both urban and emerging markets. The urology devices sector in China benefits from government healthcare reforms and the expansion of medical infrastructure in tier-2 and tier-3 cities.
  • China's emphasis on preventive care and early diagnosis is accelerating adoption of minimally invasive urological procedures and diagnostic devices.
  • Between 2025 and 2030, China is expected to see significant investment in endoscopic equipment, stone management systems, and urodynamic devices, supported by both public healthcare initiatives and private sector growth. China's competitive landscape is characterized by a mix of domestic manufacturers and international players establishing local partnerships.
  • The market's 7.8% CAGR underscores China's strategic importance in the global urology devices sector, with regulatory improvements and reimbursement policies further supporting market penetration and innovation throughout the forecast period..

Key Market Statistics

  • CAGR (2025-2030) 7.8% CAGR
  • Market Size, 2025 ~USD 2663.3 Million
  • Forecast, 2030 ~USD 3880.8 Million
  • Country China

China Urology Devices Market Overview

Aging Population Driving Demand :

China's rapidly aging demographic is significantly increasing the prevalence of urological conditions such as benign prostatic hyperplasia and urinary incontinence, creating sustained demand for advanced urology devices and treatment solutions.

Healthcare Expenditure Growth :

Rising government healthcare spending and increased out-of-pocket expenditure by Chinese consumers are expanding access to advanced urological diagnostic and therapeutic devices across urban and emerging markets.

Outpacing Global Growth :

China's urology devices market is growing at 7.8% CAGR, significantly exceeding the global average of 6%, reflecting strong market fundamentals and accelerating adoption of minimally invasive procedures.

Enhanced Diagnostic Capabilities :

Increased investment in diagnostic infrastructure and technological advancement in imaging and endoscopic devices are improving early detection and treatment outcomes for urological conditions across China's healthcare system.

China Urology Devices Market Dynamics

  • The market's 7.8% CAGR reflects strong adoption of minimally invasive technologies and improved access to advanced diagnostic tools in both metropolitan and secondary cities. Government initiatives promoting healthcare quality and increased private sector investment are expected to accelerate market expansion.
  • Rising awareness of urological health, coupled with improving reimbursement policies, will further support device adoption.
  • Strategic partnerships between international manufacturers and local distributors will enhance market penetration, particularly in tier-2 and tier-3 cities..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • China's urology devices market will grow from USD 2,663.3 million in 2025 to USD 3,880.8 million by 2030, representing a 7.8% CAGR that exceeds global growth rates.
    • China's aging demographic and rising urological disease burden are primary drivers of sustained market expansion through 2030.
    • Government healthcare reforms and infrastructure development in China are accelerating adoption of minimally invasive and diagnostic urological devices.
    • China's market attracts both domestic innovators and international manufacturers, creating a competitive environment that fosters technological advancement and market penetration.

    Urology Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment URINARY INCONTINENCE (UI) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 34.57 (2025)
    Revenue Forecast (Billions) ~USD 46.26 (2030)
    Segments Covered Product, Type, Application, End User

    China Urology Devices Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables & Accessories
    • Instruments

    By Type

    • Biopsy Devices
    • Catheters
    • Cystoscopes
    • Dialysis Consumables
    • Dialysis Devices
    • Dilator Sets & Urethral Access Sheaths
    • Drainage Bags
    • Endoscopes
    • Endoscopy Fluid Management Systems
    • Endovision & Imaging Systems
    • External Catheters
    • Guidewires
    • Hemodialysis Devices
    • Indwelling/ Foley Catheters
    • Insufflators
    • Intermittent Catheters
    • Laparoscopes
    • Laser & Lithotripsy Devices
    • Nephroscopes
    • Other Consumables & Accessories
    • Other Instruments
    • Peritoneal Dialysis Devices
    • Resectoscopes
    • Retrieval Devices & Extractors
    • Robotic Systems
    • Stents And Implants
    • Surgical Dissectors, Forceps & Needle Holders
    • Tubes & Distal Attachments
    • Ureteroscopes
    • Urodynamic Systems

    By Application

    • Benign Prostatic Hyperplasia (Bph)
    • Erectile Dysfunction
    • Kidney Diseases
    • Other Applications
    • Pelvic Organ Prolapse
    • Urinary Incontinence (Ui)
    • Urinary Stones
    • Urological Cancer

    By End User

    • Ambulatory Surgery Centers
    • Clinics
    • Dialysis Centers
    • Home Care Settings
    • Hospitals

    CHINA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGERY CENTERS136139.9144151.3160.1170.9184201.67
    CLINICS6162.463.866.670.174.479.686.76.3
    DIALYSIS CENTERS477.8500.4524.5561.1604.7657.2720.3803.38.9
    HOME CARE SETTINGS380.7396.7413.8440.4472.3510.8557618.28.4
    HOSPITALS1419.41466.71517.21601.11702.51825.41973.521717.4
    TOTAL2474.92566.12663.32820.53009.73238.73514.43880.87.8

    Target Audience

    • Medical Device Manufacturers : Manufacturers need China-specific market data to develop localized product strategies, identify distribution channels, and establish competitive positioning in this rapidly expanding 7.8% CAGR market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed China market analysis to evaluate portfolio opportunities, assess growth potential, and make informed capital allocation decisions in the urology devices sector.
    • Hospital & Healthcare Administrators : Healthcare facility leaders need market insights to optimize procurement strategies, evaluate emerging technologies, and plan capital investments in urology departments aligned with market trends.
    • Market Entry & Strategy Consultants : Consultants advising clients on China expansion require comprehensive market data to develop go-to-market strategies, competitive analyses, and feasibility assessments for urology device businesses.
    • Distributors & Trade Partners : Distribution partners need China market intelligence to identify growth segments, negotiate supplier relationships, and develop sales strategies aligned with local demand drivers and healthcare infrastructure.

    Key Companies in the China Urology Devices Market

    CompanyHQOwnershipStrongest segments
    SIEMENS HEALTHINEERSGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
    NOVANTA, INCUnited StatesPublic CompanyPrecision Medicine and Manufacturing (lasers, beam steering, robotic motion, end-of-arm tooling, spindles),Medical Solutions (insufflators, pumps, disposables, imaging, RFID, light engines, OR integration),
    LUMENIS LTDIsraelPrivate CompanySurgical,Ophthalmic,Aesthetic,
    MERIT MEDICALUnited StatesPublic CompanyCardiovascular (cardiac and peripheral intervention, access, hemostasis, fluid and hemodynamic management),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy),Endoscopy (gastroenterology and pulmonary, including stents, cryoballoon, dilators, kits),
    FRESENIUS MEDICAL CARE AG & CO. KGAAGermanyPublic CompanyCare Delivery (dialysis clinics and services),Dialysis equipment and disposables,Renal pharmaceuticals and ancillary services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, electrophysiology, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    B. BRAUN MELSUNGEN AGGermanyPrivate CompanyInfusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Standard and customized procedure kits,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (med-surg disposables, injection, vascular access, sharps),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Surgical Endoscopes & Integrated OR,Urology Solutions,
    CARDINAL HEALTHUnited StatesPublic CompanyBranded Pharmaceutical Distribution,Generic and OTC Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,
    INTUITIVE SURGICALUnited StatesPublic Companyda Vinci systems (capital),da Vinci instruments, accessories, and stapling/energy,Ion endoluminal system and accessories,
    COLOPLAST A/SDenmarkPublic CompanyOstomy Care (SenSura Mio, SenSura, Brava),Continence Care (SpeediCath, Conveen, Peristeen),Advanced Wound Dressings and Biologics (Biatain, Comfeel),
    STRYKERUnited StatesPublic CompanyOrthopaedics (hips, knees, shoulders, ankle, trauma and extremities, Mako Shoulder-linked implants),MedSurg equipment and patient handling (surgical equipment, patient and caregiver safety, emergency and ICU disposables),Neurotechnology and stroke care (navigation, endoscopy, stroke and venous thromboembolism treatment, brain and skull procedures),
    TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular and Emergency Medicine (Arrow, EZ-IO, FAST1, QuikClot),Interventional (coronary, structural heart, peripheral, closure, OnControl),Surgical (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),
    CONVATEC GROUP PLCUnited KingdomPublic CompanyAdvanced Wound Care,Ostomy Care,Continence Care,
    MEDTRONIC PLCIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),

    SIEMENS HEALTHINEERS

    Siemens Healthineers is a German public company founded in 1896 with 72,369 employees, operating in the healthcare technology sector.

    NOVANTA, INC

    Novanta, Inc. is a United States-based public company founded in 1968 with 3,000 employees.

    LUMENIS LTD

    Lumenis Ltd. is an Israeli private company founded in 1991 with 954 employees.

    MERIT MEDICAL

    Merit Medical is a United States-based public company founded in 1987 with 7,500 employees.

    FRESENIUS MEDICAL CARE AG & CO. KGAA

    Fresenius Medical Care AG & Co. KGaA is a German public company founded in 1996 with 108,165 employees, operating as a major healthcare provider.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees, specializing in medical devices.

    B. BRAUN MELSUNGEN AG

    B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical sectors.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, specializing in medical technology and diagnostics.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees, operating in imaging and medical technology.

    CARDINAL HEALTH

    Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees, operating as a healthcare services and products distributor.

    INTUITIVE SURGICAL

    Intuitive Surgical is a United States-based public company founded in 1995 with 17,021 employees, specializing in robotic surgical systems.

    COLOPLAST A/S

    Coloplast A/S is a Danish public company founded in 1954 with 17,083 employees, specializing in medical devices and healthcare products.

    STRYKER

    Stryker is a United States-based public company founded in 1941 with 56,000 employees, operating in medical technology and surgical equipment.

    TELEFLEX INCORPORATED

    Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees, specializing in medical devices.

    CONVATEC GROUP PLC

    ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees, operating in medical technology and healthcare products.

    MEDTRONIC PLC

    Medtronic PLC is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation for China (USD 2,663.3M in 2025) and verified 5-year forecast data to support investment decisions, business planning, and competitive positioning in this high-growth market.
    • Demographic & Clinical Insights : Understand China's aging population dynamics and rising urological disease prevalence to identify target patient segments, develop localized marketing strategies, and align product portfolios with market needs.
    • Competitive Landscape Analysis : Gain intelligence on market dynamics, key players, and competitive positioning specific to China to inform market entry strategies, partnership opportunities, and differentiation approaches.
    • Regulatory & Reimbursement Environment : Access critical information on China's healthcare policies, reimbursement frameworks, and regulatory pathways to navigate market entry, pricing strategies, and compliance requirements effectively.
    • Growth Opportunity Identification : Identify high-potential segments, emerging technologies, and geographic expansion opportunities within China's urology market to prioritize resource allocation and maximize ROI.

    Frequently asked questions

    What is the projected market size of urology devices in China by 2030?

    China's urology devices market is projected to reach USD 3,880.8 million by 2030, up from USD 2,663.3 million in 2025.

    What is the CAGR for China's urology devices market?

    China's urology devices market is expected to grow at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2030.

    What factors are driving growth in China's urology devices market?

    Key drivers include China's aging population, rising prevalence of urological conditions, government healthcare reforms, infrastructure expansion, and increased adoption of minimally invasive procedures.

    How does China's market growth compare to global trends?

    China's 7.8% CAGR outpaces the global urology devices market CAGR of 6%, reflecting China's strategic importance and accelerating healthcare modernization.

    What types of urology devices are in demand in China?

    China shows strong demand for endoscopic equipment, stone management systems, urodynamic devices, and diagnostic tools, particularly for minimally invasive procedures.

    RESEARCH METHODOLOGY

    This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global urology devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), US Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

    Urology Devices Market 
 Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the urology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Urology Devices Market : Top-Down and Bottom-Up Approach

    Urology Devices Market  Top Down and Bottom Up Approach

    Data Triangulation

    The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Urology is a medical specialty that deals with the physiology, diseases, and disorders of the human urinary tract and male reproductive organs. Urology devices comprise various types of equipment used during the diagnosis, surgery, and treatment of urological diseases, such as chronic kidney diseases, renal failure, urinary stones, benign prostate hyperplasia (BPH), pelvic organ prolapse (POP), prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction.

    Key Stakeholders

    • Manufacturers and Distributors of Urology Devices
    • Hospitals and ASCs
    • Academic Research Institutes
    • Urology Clinics
    • Urology Device Service Providers
    • Venture Capitalists and Investors
    • Clinical Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the urology devices market by product, application, end user, and region
    • To forecast the size of the urology devices market with respect to five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall urology devices market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile the key players in the urology devices market and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
    • To track and analyze competitive developments such as product launches, product approvals, mergers, agreements, collaborations, partnerships, expansions, and acquisitions in the urology devices market
    • To benchmark players within the urology devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

    To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the urology devices market

    Customization Options

    With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

    Portfolio Assessment

    • Product Matrix gives a detailed comparison of the product portfolios of the top five companies.

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Geographical Analysis

    • A further breakdown of the Rest of Europe’s urology devices market into countries
    • A further breakdown of the Rest of Asia Pacific’s urology devices market into countries
    • A further breakdown of Latin America’s urology devices market into countries

    Get the Full Urology Devices Market Report

    Full forecast, segment splits, and company analysis for all Urology Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status